Salesforce shares rise as investors focus on Agentforce momentum and fresh public-sector wins

Salesforce (CRM) is up 3.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to renewed optimism around Salesforce’s Agentforce strategy, helped by recent public-sector adoption headlines and expanding partner infrastructure for its AI-first contact-center offering. With the stock still sensitive to growth and AI monetization narratives, incremental deal signals can have an outsized impact on sentiment.

Details:

Salesforce highlighted major U.S. government adoption of Agentforce, including a large U.S. Army award focused on modernization and building an “agent-ready” data and workflow foundation.

Additional federal momentum has been visible in 2026, including a Department of Labor rollout of Agentforce to enhance citizen support through a modernized national contact center.

A recent Air Force procurement update described access to Salesforce capabilities and the ability to pilot Agentforce as part of personnel modernization work, reinforcing the view that agentic AI is moving from demos to deployments.

Separately, a communications-technology partner announced work supporting Salesforce’s Agentforce Contact Center in public cloud deployments, which could be read as strengthening the ecosystem needed for scaled enterprise rollouts.

Sources:

Salesforce Investor Relations, PR Newswire, Nextgov/FCW

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CRM Insider Trading Activity

$CRM insiders have traded $CRM stock on the open market 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.

Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:

PARKER HARRIS (Co-Founder and CTO, Slack) has made 0 purchases and 5 sales selling 134,662 shares for an estimated $31,605,031.
G MASON MORFIT purchased 96,000 shares for an estimated $25,015,680
DAVID BLAIR KIRK has made 2 purchases buying 4,506 shares for an estimated $1,000,900 and 0 sales.
NEELIE KROES sold 3,893 shares for an estimated $929,275
LAURA ALBER has made 2 purchases buying 2,571 shares for an estimated $500,266 and 0 sales.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CRM Hedge Fund Activity

We have seen 1,259 institutional investors add shares of $CRM stock to their portfolio, and 1,704 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

J. STERN & CO. LLP added 47,189,352 shares (+24056.7%) to their portfolio in Q4 2025, for an estimated $12,500,931,238
CAPITAL INTERNATIONAL INVESTORS removed 10,096,552 shares (-44.4%) from their portfolio in Q1 2026, for an estimated $1,881,795,361
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 7,160,302 shares (+130.2%) to their portfolio in Q1 2026, for an estimated $1,334,537,086
JPMORGAN CHASE & CO removed 6,496,920 shares (-49.8%) from their portfolio in Q4 2025, for an estimated $1,721,099,077
CAPITAL RESEARCH GLOBAL INVESTORS added 4,237,753 shares (+44.8%) to their portfolio in Q1 2026, for an estimated $789,832,404
AMERIPRISE FINANCIAL INC added 3,930,311 shares (+80.5%) to their portfolio in Q4 2025, for an estimated $1,041,178,687
INDEPENDENT FRANCHISE PARTNERS LLP added 3,497,051 shares (+650.0%) to their portfolio in Q1 2026, for an estimated $651,780,365

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CRM Congressional Stock Trading

Members of Congress have traded $CRM stock 8 times in the past 6 months. Of those trades, 4 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:

REPRESENTATIVE MARIA ELVIRA SALAZAR purchased up to $50,000 on 04/06.
REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 2 purchases worth up to $30,000 on 02/09, 01/29 and 2 sales worth up to $65,000 on 02/26.
REPRESENTATIVE JULIA LETLOW has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/02, 12/16.
SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CRM Analyst Ratings

Wall Street analysts have issued reports on $CRM in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Piper Sandler issued a "Overweight" rating on 02/26/2026
BTIG issued a "Buy" rating on 12/17/2025
Needham issued a "Buy" rating on 12/04/2025
BMO Capital issued a "Outperform" rating on 12/04/2025
Wedbush issued a "Outperform" rating on 12/04/2025
Baird issued a "Outperform" rating on 12/04/2025
Citizens issued a "Market Outperform" rating on 12/04/2025

To track analyst ratings and price targets for $CRM, check out Quiver Quantitative's $CRM forecast page.

$CRM Price Targets

Multiple analysts have issued price targets for $CRM recently. We have seen 32 analysts offer price targets for $CRM in the last 6 months, with a median target of $257.5.

Here are some recent targets:

Tyler Radke from Citigroup set a target price of $188.0 on 05/12/2026
Allan Verkhovski from BTIG set a target price of $255.0 on 04/17/2026
Billy Fitzsimmons from Piper Sandler set a target price of $215.0 on 04/14/2026
Nehal Chokshi from Northland Capital Markets set a target price of $229.0 on 03/10/2026
Gil Luria from DA Davidson set a target price of $200.0 on 02/27/2026
Parker Lane from Stifel set a target price of $250.0 on 02/26/2026
Scott Berg from Needham set a target price of $400.0 on 02/26/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.